MIBI INSTITUTE OF ATOMIC ENERGY 1 mg EQUIPO DE REACTIVOS PARA PREPARACION RADIOFARMACEUTICA EFG España - español - AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)

mibi institute of atomic energy 1 mg equipo de reactivos para preparacion radiofarmaceutica efg

narodowe centrum badan jadrowych - [tetrakis (2-metoxi-2-metilpropil-1-isocianuro) cobre (i)], tetrafluoroborato de - equipo de reactivos para preparaciÓn radiofarmacÉutica - 1 mg - [tetrakis (2-metoxi-2-metilpropil-1-isocianuro) cobre (i)], tetrafluoroborato de 1 mg - tecnecio (99mtc) sestamibi

Improvac Unión Europea - español - EMA (European Medicines Agency)

improvac

zoetis belgium sa - synthetic peptide analogue of gnrf conjugated to diptheria toxoid - inmunológicos para suidos - male pigs (from 8 weeks of age); female pigs (from 14 weeks of age) - male pigs:induction of antibodies against gnrf to produce a temporary immunological suppression of testicular function. for use as an alternative to physical castration for the reduction of boar taint caused by the key boar taint compound androstenone, in entire male pigs following the onset of puberty. otro factor clave para la contaminación del verraco, el escatol, también se puede reducir como un efecto indirecto. los comportamientos agresivos y sexuales (de montaje) también se reducen. female pigs:induction of antibodies against gnrf to produce a temporary immunological suppression of ovarian function (suppression of oestrus) in order to reduce the incidence of unwanted pregnancies in gilts intended for slaughter, and to reduce the associated sexual behaviour (standing oestrus).

Palforzia Unión Europea - español - EMA (European Medicines Agency)

palforzia

aimmune therapeutics ireland limited - defatted powder of arachis hypogaea l., semen (peanuts) - peanut hypersensitivity - allergens - palforzia is indicated for the treatment of patients aged 4 to 17 years with a confirmed diagnosis of peanut allergy. palforzia may be continued in patients 18 years of age and older. palforzia should be used in conjunction with a peanut-avoidant diet.

Cancidas (previously Caspofungin MSD) Unión Europea - español - EMA (European Medicines Agency)

cancidas (previously caspofungin msd)

merck sharp & dohme b.v. - caspofungin (as acetate) - candidiasis; aspergillosis - antimicóticos para uso sistémico - treatment of invasive candidiasis in adult or paediatric patients;treatment of invasive aspergillosis in adult or paediatric patients who are refractory to or intolerant of amphotericin b, lipid formulations of amphotericin b and / or itraconazole. refractoriness is defined as progression of infection or failure to improve after a minimum of seven days of prior therapeutic doses of effective antifungal therapy;empirical therapy for presumed fungal infections (such as candida or aspergillus) in febrile, neutropaenic adult or paediatric patients.

VACUNA BCG Cuba - español - CECMED (Autoridad Reguladora de Medicamentos, Equipos y Dispositivos Médicos)

vacuna bcg

serum institute of india pvt. ltd., edificio no. 4, primer piso - suspensión bacteriana de bcg - liofilizado para suspensión inyectable, id. - 2 -8 x 10^5 ufc/0,1 ml

Segluromet Unión Europea - español - EMA (European Medicines Agency)

segluromet

merck sharp & dohme b.v. - ertugliflozin l-pyroglutamic acid, metformin hydrochloride - diabetes mellitus, tipo 2 - drugs used in diabetes, combinations of oral blood glucose lowering drugs - segluromet is indicated in adults aged 18 years and older with type 2 diabetes mellitus as an adjunct to diet and exercise to improve glycaemic control:in patients not adequately controlled on their maximally tolerated dose of metformin alonein patients on their maximally tolerated doses of metformin in addition to other medicinal products for the treatment of diabetesin patients already being treated with the combination of ertugliflozin and metformin as separate tablets.

LEVOFLOXACINO Cuba - español - CECMED (Autoridad Reguladora de Medicamentos, Equipos y Dispositivos Médicos)

levofloxacino

unique pharmaceutical laboratories (a div. of j.b chemicals & pharmaceuticals limited), plot no. 4 - levofloxacino (eq. a 513,875 mg de levofloxacino hemihidrato) - infusión iv - 500 mg/100 ml